Selected References:

  • Briggs GG, et al. 2005. Drugs in pregnancy and lactation, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins.
  • Carmichael SL, et al. 2007. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol; 197(6):585.e1-585.e7.
  • Constantinescu S, et al. 2014. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol; 28(8):1163-73. Fitzsimons R, et al. 1986. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol; 78(2):349-53.
  • Gomaa MF, et al. 2014. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cerlls and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial. Arch Gynecol Obstet DOI 10.1007/s00404-014-3262-0.
  • Ito S, et al. 1993. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol; 168:1393-9.
  • Man YA, et al. 2009. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum; 60(11):3196-3206.
  • Nørgård B, et al. 2007. Therapeutic drug use in women with crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol; 102:1406-13.
  • Nyberg G, et al. 1998. Breast-feeding during treatment with cyclosporine. Transplantation;65:253-5.
  • Ost L, et al. 1985. Prednisolone excretion in human milk. J Pediatr; 106:1008-11.
  • Park-Wyllie L, et al. 2000. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology; 62(6):385-92.
  • Petri M, et al. 1992. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol; 28(3-4):188-91.
  • Pradat P, et al. 2003. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol; 67(12):968-70.
  • Rodríguez-Pinilla E & Martínez-Frías ML. 1998. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology; 58(1):2-5.
  • Skuladottir H, et al. 2014. Corticosteroid use and risk of orofacial clefts. Birth Defects Res (Part A) 100: 499-506.
  • Silver RK, et al. 1993. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody – positive obstetrics patients. Am J Obstet Gynecol; 169(6):1411-7.
  • Tata LJ, et al. 2008. Effects of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax; 63(11):981-87.
  • Van Zutphen AR, et al, National Birth Defects Prevention Study. 2015. Maternal asthma medication use during pregnancy and risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol; 103(11):951-61.